Form 4: ICU Medical CFO Brian Bonnell Reports Stock Transactions
SEC Form 4
Brian Michael Bonnell, CFO of ICU Medical, reports the vesting and disposal of restricted stock units.
Summary
- Brian Michael Bonnell, the Chief Financial Officer of ICU Medical Inc., reported transactions involving restricted stock units on March 7, 2025.
- A total of 2,146 restricted stock units vested and were subsequently disposed of at a price of $0.0.
- Following these transactions, Bonnell directly owns 27,100 shares of common stock and 10,566 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by a company executive, indicating a neutral sentiment.
Industry Context
This is a routine disclosure of insider transactions, common for executives holding company stock and stock-based compensation.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders, as they represent routine executive compensation and stock disposal.
Key Dates
| Date | Description |
|---|---|
| 03/07/2023 | Date related to the vesting schedule of the restricted stock units. |
| 03/07/2025 | Date of the reported transactions: vesting and disposal of restricted stock units. |
| 03/10/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.